- Gainers: Obalon Therapeutics (NASDAQ:OBLN) +41%. Dova Pharmaceuticals (NASDAQ:DOVA) +21%. Translate Bio (NASDAQ:TBIO) 20%. Spectrum Pharmaceuticals (NASDAQ:SPPI) +18%. Check-Cap (NASDAQ:CHEK) +15%.
- Losers: TRACON Pharmaceuticals (NASDAQ:TCON) -29%. Perrigo Company (NASDAQ:PRGO) -24%. Therapix Biosciences (NASDAQ:TRPX) -16%. Benitec Biopharma (NASDAQ:BNTC) -15%. Zomedica Pharmaceuticals (NASDAQ:ZOM) -12%.